6-(2-amino-1,3-benzoxazol-5-yl)-N-[2-(4-methylpiperazin-1-yl)ethyl]imidazo[1,2-a]pyridine-3-carboxamide
C22H25N7O2 — CID 70798553
Data last refreshed: (MolForge compound catalog, from PubChem)
About 6-(2-amino-1,3-benzoxazol-5-yl)-N-[2-(4-methylpiperazin-1-yl)ethyl]imidazo[1,2-a]pyridine-3-carboxamide
6-(2-amino-1,3-benzoxazol-5-yl)-N-[2-(4-methylpiperazin-1-yl)ethyl]imidazo[1,2-a]pyridine-3-carboxamide (PubChem CID 70798553) has the molecular formula C22H25N7O2 and a molecular weight of 419.49 g/mol. Its IUPAC name is 6-(2-amino-1,3-benzoxazol-5-yl)-N-[2-(4-methylpiperazin-1-yl)ethyl]imidazo[1,2-a]pyridine-3-carboxamide.
Molecular Properties
| Compound Name | 6-(2-amino-1,3-benzoxazol-5-yl)-N-[2-(4-methylpiperazin-1-yl)ethyl]imidazo[1,2-a]pyridine-3-carboxamide |
|---|---|
| PubChem CID | 70798553 |
| Molecular Formula | C22H25N7O2 |
| Molecular Weight | 419.49 g/mol |
| Exact Mass | 419.21 |
| IUPAC Name | 6-(2-amino-1,3-benzoxazol-5-yl)-N-[2-(4-methylpiperazin-1-yl)ethyl]imidazo[1,2-a]pyridine-3-carboxamide |
| SMILES | CN1CCN(CCNC(=O)c2cnc3ccc(-c4ccc5oc(N)nc5c4)cn23)CC1 |
| InChI | InChI=1S/C22H25N7O2/c1-27-8-10-28(11-9-27)7-6-24-21(30)18-13-25-20-5-3-16(14-29(18)20)15-2-4-19-17(12-15)26-22(23)31-19/h2-5,12-14H,6-11H2,1H3,(H2,23,26)(H,24,30) |
| InChIKey | VCCAQMQCZHPVKZ-UHFFFAOYSA-N |
| XLogP | 1.70 |
| TPSA | 104.93 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 31 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 419.49 |
| LogP ≤ 5 | 1.70 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 70798553 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.